CD274 and brain germinoma: Immunohistochemical staining of intracranial germinomas revealed that 90% stained positively for programmed death receptor ligand 1 (PD-L1), indicating that anti-PD-1 and anti-PD-L1 may have a future role in the treatment of intracranial germinomas [97].